Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Live attenuated and inactivated influenza vaccines in children.

Ilyushina NA, Haynes BC, Hoen AG, Khalenkov AM, Housman ML, Brown EP, Ackerman ME, Treanor JJ, Luke CJ, Subbarao K, Wright PF.

J Infect Dis. 2015 Feb 1;211(3):352-60. doi: 10.1093/infdis/jiu458. Epub 2014 Aug 26.

2.

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.

Rudenko L, Naykhin A, Donina S, Korenkov D, Petukhova G, Isakova-Sivak I, Losev I, Stukova M, Erofeeva M, Nikiforova A, Power M, Flores J.

Hum Vaccin Immunother. 2015;11(12):2839-48. doi: 10.1080/21645515.2015.1069931.

3.

Localized mucosal response to intranasal live attenuated influenza vaccine in adults.

Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.

J Infect Dis. 2013 Jan 1;207(1):115-24. doi: 10.1093/infdis/jis641. Epub 2012 Oct 19.

4.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, McLean HQ, Fry AM.

Pediatrics. 2016 Feb;137(2):e20153279. doi: 10.1542/peds.2015-3279. Epub 2016 Jan 5.

5.

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.

Chen GL, Lau YF, Lamirande EW, McCall AW, Subbarao K.

Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1140-5. doi: 10.1073/pnas.1009908108. Epub 2011 Jan 3.

6.

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.

J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23.

PMID:
21949042
7.

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J.

Vaccine. 2011 Nov 21;29(50):9391-7. doi: 10.1016/j.vaccine.2011.09.109. Epub 2011 Oct 6.

PMID:
21983154
8.

Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines.

Sasaki S, Holmes TH, Albrecht RA, García-Sastre A, Dekker CL, He XS, Greenberg HB.

J Infect Dis. 2014 Sep 15;210(6):865-74. doi: 10.1093/infdis/jiu190. Epub 2014 Mar 27.

9.

Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.

Bethell D, Saunders D, Jongkaewwattana A, Kramyu J, Thitithayanont A, Wiboon-ut S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Uthaimongkol N, Garcia JM, Timmermans AE, Peiris M, Thomas S, Engering A, Jarman RG, Mongkolsirichaikul D, Mason C, Khemnu N, Tyner SD, Fukuda MM, Walsh DS, Pichyangkul S.

PLoS One. 2013;8(3):e59674. doi: 10.1371/journal.pone.0059674. Epub 2013 Mar 26.

10.

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.

Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.

PMID:
19095024
11.

Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O.

J Infect Dis. 2014 Jul 15;210(2):224-33. doi: 10.1093/infdis/jiu079. Epub 2014 Feb 4.

12.

Measuring antibody responses to a live attenuated influenza vaccine in children.

Lee MS, Mahmood K, Adhikary L, August MJ, Cordova J, Cho I, Kemble G, Reisinger K, Walker RE, Mendelman PM.

Pediatr Infect Dis J. 2004 Sep;23(9):852-6.

PMID:
15361726
13.

T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Li J, Arévalo MT, Chen Y, Chen S, Zeng M.

Int J Infect Dis. 2014 Oct;27:37-43. doi: 10.1016/j.ijid.2014.05.016. Epub 2014 Aug 27.

14.

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

Halliley JL, Khurana S, Krammer F, Fitzgerald T, Coyle EM, Chung KY, Baker SF, Yang H, Martínez-Sobrido L, Treanor JJ, Subbarao K, Golding H, Topham DJ, Sangster MY.

J Infect Dis. 2015 Oct 15;212(8):1270-8. doi: 10.1093/infdis/jiv210. Epub 2015 Apr 2.

15.

Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.

Kahn KE, Santibanez TA, Zhai Y, Singleton JA.

Vaccine. 2015 Sep 22;33(39):5196-203. doi: 10.1016/j.vaccine.2015.07.064. Epub 2015 Aug 1.

16.

Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Huber VC, Kleimeyer LH, McCullers JA.

Vaccine. 2008 Oct 3;26(42):5381-8. doi: 10.1016/j.vaccine.2008.07.086. Epub 2008 Aug 15.

17.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group..

Vaccine. 2015 Jan 15;33(4):535-41. doi: 10.1016/j.vaccine.2014.11.044. Epub 2014 Dec 6.

18.

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.

Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X.

Hum Vaccin Immunother. 2015;11(7):1648-53. doi: 10.1080/21645515.2015.1037998.

19.

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.

Weinberg A, Song LY, Fenton T, Nachman SA, Read JS, Patterson-Bartlett J, Levin MJ.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):51-9. doi: 10.1089/aid.2009.0163.

20.

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.

Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE.

J Infect Dis. 2015 Oct 15;212(8):1191-9. doi: 10.1093/infdis/jiv195. Epub 2015 Apr 8.

PMID:
25858957

Supplemental Content

Support Center